New York City confronts a winter surge in respiratory illnesses, with a 70% increase in flu cases and ongoing COVID-19 presence, while RSV shows a slight decrease.

New York introduces 20 hours of paid prenatal leave for private-sector workers starting January 1, aiming to improve access to prenatal care without income loss.

New York hospitals are preparing for financial strain in 2025 due to expected federal funding cuts, impacting Medicare, Medicaid, and other crucial programs.

New York faces a surge in respiratory illnesses including RSV, flu, and COVID, prompting mask mandates for healthcare workers and recommendations for public precautions.

Costco issued a recall for 24-count eggs from Handsome Brook Farms due to a salmonella risk classified by the FDA as a Class I recall. No illnesses have been reported, but consumers are advised to return or discard the affected eggs.

Anthem and Memorial Sloan Kettering reach an agreement to maintain in-network rates for Anthem members, ensuring continued cancer care without added financial stress.

Federal authorities have approved a tax on Managed Care Organizations in New York, a measure expected to generate significant funds for the state's Medicaid budget.

U.S. flu cases are surging with low vaccination rates reported, prompting health officials to urge vaccinations amid rising flu and other respiratory illnesses.

Funding for the World Trade Center Health Program was excluded from Congress's budget bill, eliciting disappointment from New York's fire unions and advocates for 9/11 first responders.

A judge halted the eviction of over 300 nursing home residents and ordered staff payment at Cold Spring Hills in Long Island during legal battles over the facility's financial woes.

The NYSNA report accuses many New York hospitals of failing to comply with state law regarding nurse staffing levels, compromising patient care and safety.

New York’s Court of Appeals ruled that the city must pay for the chosen health plans of retirees, blocking an attempt to transition them to a privatized Medicare Advantage plan.

Pfizer projects 2025 revenue aligning with analysts' expectations and announces additional cost cuts amid criticisms of management and challenges such as the impact of Medicare policy changes.